Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
Kristin K Jørgensen, Guro L Goll, Joe Sexton, Nils Bolstad, Inge C Olsen, Øivind Asak, Ingrid P Berset, Ingrid M Blomgren, Katrine Dvergsnes, Jon Florholmen, Svein O Frigstad, Magne Henriksen, Jon Hagfors, Gert Huppertz-Hauss, Espen A Haavardsholm, Rolf A Klaasen, Bjørn Moum, Geir Noraberg, Ulf Prestegård, Jan H Rydning, Liv Sagatun, Kathrine A Seeberg, Roald Torp, Cecilia Vold, David J Warren, Carl M Ystrøm, Knut E A Lundin, Tore Kvien, Jørgen Jahnsen
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2021;34(5):681-694